Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.41 EUR | +7.34% |
|
+10.22% | -15.45% |
03:15pm | InMode Says FDA Clears Morpheus8 Technology for Soft Tissue Contraction | MT |
Jul. 15 | Barclays Lowers Price Target on InMode to $29 From $33, Maintains Overweight Rating | MT |